As part of Xenon's ongoing collaboration with Neurocrine Biosciences, a Phase 1 study is underway of NBI-921355, an investigational, selective inhibitor of voltage-gated sodium channels Nav1.2 and ...

Epilepsy, one of the most common neurological disorders characterized by recurrent seizures, affects over 70 million people worldwide.

Epilepsy, one of the most common neurological disorders characterized by recurrent seizures, affects over 70 million people worldwide. In the United States, about 3.4 million people live with this ...

Epilepsy, one of the most common neurological disorders characterized by recurrent seizures, affects over 70 million ...